Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Cytokine-cytokine receptor interaction | R-HSA-6788467 | map04060 | hydroxyachillin | 6713966 | drug-path |
| Ribosome | R-HSA-5368277 | map03010 | hydroxyachillin | 6713966 | drug-path |
| Calcium signaling pathway | R-HSA-381753 | map04020 | hydroxyachillin | 6713966 | drug-path |
| Proteasome | R-HSA-68819 | map03050 | hydroxyachillin | 6713966 | drug-path |
| ABC transporters | R-HSA-1369007 | map02010 | hydroxyachillin | 6713966 | drug-path |
| Complement and coagulation cascades | R-HSA-114591 | map04610 | hydroxyachillin | 6713966 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | glimepiride | 5258 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | glimepiride | 5258 | drug-path |
| Axon guidance | R-HSA-422475 | map04360 | glimepiride | 5258 | drug-path |
| Regulation of actin cytoskeleton | R-HSA-392751 | map04810 | glimepiride | 5258 | drug-path |
| Gap junction | R-HSA-190861 | map04540 | glimepiride | 5258 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | vitexin | 5280441 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | vitexin | 5280441 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | vitexin | 5280441 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | vitexin | 5280441 | drug-path |
| Phosphatidylinositol signaling system | R-HSA-1280215 | map04070 | vitexin | 5280441 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | vitexin | 5280441 | drug-path |
| Notch signaling pathway | R-HSA-157118 | map04330 | vitexin | 5280441 | drug-path |
| Alzheimer's disease | R-HSA-1643685 | 0 | Prestwick-691 | None | drug-path |
| Wnt signaling pathway | R-HSA-195721 | map04310 | Prestwick-691 | None | drug-path |